Avant-garde Health, Inc.

Founded in 2014, and based in Massachusetts, US, Avant-garde Health, Inc. operates as a provider of healthcare software solutions. The company was founded by its CEO, Derek Haas. The company was formed out of Harvard Business School’s value-based health care delivery research, which was led by Professors Michael Porter and Robert Kaplan.

In March 2022, Avant-garde Health, Inc. raised USD 12. 55 million in a Series A funding led by new investor Fulcrum Equity Partners, with participation from another new investor, Sparta Group, and returning investor, General Catalyst Partners. As of 2022, the company employs around 20 employees.

Avant-garde offers surgical care measurement software that helps healthcare organizations such as hospitals, health systems, and surgery centers save money by delivering insights, improving patient outcomes, making data-driven decisions, and increasing physician participation. Among its clients are the Gundersen Health System, the University of Arkansas for Medical Sciences, and Penn State Health Hershey Medical Center. The company's services include financial, clinical, and operational insights such as whether to invest in more expensive surgical gear for better results and what team composition provides the best surgery results. Hospitals can also use the company's Medicare-based bundled payment solutions to manage reimbursement and payment programs.

The company plans to use the March 2022 funding to support its ongoing research, hire new staffers, and expand its platform to more health systems.